糖尿病性胃不全麻痺(Diabetic Gastroparesis):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Gastroparesis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Diabetic Gastroparesis 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Diabetic Gastroparesis 29
Apr 16, 2015: Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis 29
Apr 08, 2015: Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis 29
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Evoke Pharma, Inc. 31
Clinical Trial Overview of Evoke Pharma, Inc. 31
Rhythm Pharmaceuticals 32
Clinical Trial Overview of Rhythm Pharmaceuticals 32
Ocera Therapeutics, Inc. 33
Clinical Trial Overview of Ocera Therapeutics, Inc. 33
Ironwood Pharmaceuticals, Inc. 34
Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 34
Theravance, Inc. 35
Clinical Trial Overview of Theravance, Inc. 35
Targacept, Inc. 36
Clinical Trial Overview of Targacept, Inc. 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Alfa Wassermann S.p.A 38
Clinical Trial Overview of Alfa Wassermann S.p.A 38
Chong Kun Dang Pharmaceutical Corp. 39
Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp. 39
Axis Clinical Trials 40
Clinical Trial Overview of Axis Clinical Trials 40
Clinical Trial Overview of Top Institutes / Government 41
Dartmouth-Hitchcock Medical Center 41
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 41
Duke University Medical Center 42
Clinical Trial Overview of Duke University Medical Center 42
Malmo University Hospital 43
Clinical Trial Overview of Malmo University Hospital 43
Qingdao University 44
Clinical Trial Overview of Qingdao University 44
Rabin Medical Center 45
Clinical Trial Overview of Rabin Medical Center 45
University of Calgary 46
Clinical Trial Overview of University of Calgary 46
Vienna General Hospital 47
Clinical Trial Overview of Vienna General Hospital 47
Yokohama City University 48
Clinical Trial Overview of Yokohama City University 48
Five Key Clinical Profiles 49
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74


【レポート販売概要】

■ タイトル:糖尿病性胃不全麻痺(Diabetic Gastroparesis):世界の治験レビュー(2015年上半期版)
■ 英文:Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015
■ 発行日:2015年5月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC2673CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。